HMI-115 demonstrates statistically significant improvement of endometriosis-related pain Dysmenorrhea NRS scores decreased by 41.57%, 34.72%, and 27.35% across the three dosage groups Non-menstrual pelvic pain NRS scores decreased across all HMI-115 dosage groups, with sustained efficacy...
Hence then, the article about hmi 115 a potential first in class treatment for endometriosis published proof of concept phase ii clinical trial results in the lancet obstetrics gynaecology women s health was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health )
Also on site :
- Germany’s Merz changes stance on Russia
- Tokyo's Yamanote Line suspended due to power outage
- Tokyo's Yamanote loop line trains out of service due to power outage